The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

51 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of new nanomolar inhibitors of GPa: Extension of 2-oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors.EBI
Griffith University
Synthetic, enzyme kinetic, and protein crystallographic studies of C-ß-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.EBI
University of Thessaly
Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.EBI
Egypt National Research Centre
2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: Design, synthesis and structure-activity relationship study.EBI
Griffith University
4(5)-Aryl-2-C-glucopyranosyl-imidazoles as New Nanomolar Glucose Analogue Inhibitors of Glycogen Phosphorylase.EBI
University of Debrecen
Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.EBI
Claude Bernard University Lyon 1
Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-ß-d-glucopyranosylamines.EBI
University of Thessaly
New synthesis of 3-(ß-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase.EBI
University of Debrecen
A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis.EBI
University of Alcala
Synthesis, enzyme kinetics and computational evaluation of N-(ß-D-glucopyranosyl) oxadiazolecarboxamides as glycogen phosphorylase inhibitors.EBI
University of Debrecen
C-Glucopyranosyl-1,2,4-triazoles As New Potent Inhibitors of Glycogen Phosphorylase.EBI
University of Debrecen
Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.EBI
University of Debrecen
The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment.EBI
University of Thessaly
Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.EBI
University of Lyon
1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.EBI
National Hellenic Research Foundation
Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.EBI
China Pharmaceutical University
Practical synthesis of bredemolic acid, a natural inhibitor of glycogen phosphorylase.EBI
China Pharmaceutical University
Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.EBI
China Pharmaceutical University
Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases.EBI
China Pharmaceutical University
Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors.EBI
Johnson & Johnson Pharmaceutical Research and Development
Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.EBI
Novo Nordisk
Efficient inhibition of muscle and liver glycogen phosphorylases by a new glucopyranosylidene-spiro-thiohydantoin.EBI
Lajos Kossuth University
N-(4-Substituted-benzoyl)-N'-(ß-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.EBI
University of Debrecen
Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid.EBI
China Pharmaceutical University
Halogen-substituted (C-ß-D-glucopyranosyl)-hydroquinone regioisomers: synthesis, enzymatic evaluation and their binding to glycogen phosphorylase.EBI
National Hellenic Research Foundation
Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.EBI
Applied Science University
Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.EBI
Chinese Academy of Sciences
Efficient synthesis and biological evaluation of epiceanothic acid and related compounds.EBI
China Pharmaceutical University
The binding ofß-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.EBI
National Hellenic Research Foundation
Synthesis of 3-deoxypentacyclic triterpene derivatives as inhibitors of glycogen phosphorylase.EBI
China Pharmaceutical University
Synthesis of 1-(D-glucopyranosyl)-1,2,3-triazoles and their evaluation as glycogen phosphorylase inhibitors.EBI
University of Debrecen
Synthesis and glycogen phosphorylase inhibitory activity of N-(beta-D-glucopyranosyl)amides possessing 1,4-benzodioxane moiety.EBI
University of Debrecen
Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase.EBI
University of Debrecen
Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase.EBI
University of Debrecen
Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.EBI
Metabasis Therapeutics
Novel design principle validated: glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent.EBI
University of Debrecen
Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitors.EBI
Griffith University
Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.EBI
The National Hellenic Research Foundation
Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.EBI
China Pharmaceutical University
Novel 3,4-dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase a.EBI
Merck Research Laboratories
A new class of glycogen phosphorylase inhibitors.EBI
Merck Research Laboratories
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.EBI
Merck Research Laboratories
Synthesis, screening and docking of small heterocycles as glycogen phosphorylase inhibitors.EBI
Griffith University
Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods.EBI
University of Debrecen
A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.EBI
University of Debrecen
Nanomolar Inhibitors of Glycogen Phosphorylase Based onβ-d-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study.EBI
University of Debrecen
Heterocyclylamines as PI3K inhibitorsBDB
Incyte Holdings
Carbazole compounds useful as bromodomain inhibitorsBDB
Bristol-Myers Squibb
Tetrahydropyranyl benzamide derivativesBDB
Eli Lilly
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent.BDB
Merck Research Laboratories